Systemic treatment for hepatocellular carcinoma. Issue 3 (1st September 2018)

• Record Type: Journal Article
• Authors: Aggarwal, Manushi; Arain, Abeer; Jin, Zhaohui
• Is Part Of: Chronic diseases and translational medicine. Volume 4:Issue 3(2018)
• Page Start: 148
• Page End: 155
• Publication Date: 2018-09-01
• Subjects: Hepatocellular carcinoma -- Systemic treatment -- Immunotherapy -- Tyrosine kinase inhibitor; Chronic diseases -- Periodicals; Medicine -- Research -- Periodicals; Chronic diseases; Medicine -- Research; Chronic Disease; Translational Medical Research; Periodicals; Electronic journals; Fulltext; Internet Resources; Periodicals; Periodical; 616.044
• DOI: 10.1016/j.cdtm.2018.08.003
• Languages: English
• ISSNs: 2095-882X

Abstract

Abstract: Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality worldwide. Treatment options for patients with advanced stage HCC remain a great challenge. However, novel agents especially small molecule tyrosine kinase inhibitor and innovative immunotherapy demonstrate new promising therapeutic options for these patients. This review article summarizes systemic treatment options evaluated in HCC focusing on the most recently published data and ongoing studies.